BCL2L1 and head and neck carcinoma: Inhibition of STAT5b, but not of STAT5a, in xenograft models of head and neck carcinomas via antisense oligonucleotides repressed tumor growth and hindered expression of the STAT5-regulated genes cyclin D1 and Bcl-XL [13,14].